Efavirenz and nevirapine are potent inhibitors of CYP3A4 and are predicted increase the metabolism of aripiprazole. The manufacturers recommend using double the dose of aripiprazole, then titrating to effect.
(12)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.